Verrica Pharmaceuticals (VRCA) Earnings Date & Reports

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

VRCA is expected to report earnings to rise 45.88% to -11 cents per share on August 12

Verrica Pharmaceuticals VRCA Stock Earnings Reports

Q2'25

Est.

$-0.12

Q1'25

Beat

by $0.03

Q4'24

Beat

by $0.06

Q3'24

Missed

by $0.05

Q2'24

Beat

by $0.04

The last earnings report on May 13 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 164.74K shares outstanding, the current market capitalization sits at 50.85M.

View a ticker or compare two or three

Compare

VRCA